e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
Epidemiology of respiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dealing with missing longitudinal FEV1 observations when used as time-dependent covariate data in survival analysis for COPD patients within a regional UK population-level database
David Culliford (Southampton, United Kingdom), David Culliford, Matt Johnson, Lynn Josephs
Source:
International Congress 2015 – Epidemiology of respiratory disease
Session:
Epidemiology of respiratory disease
Session type:
Poster Discussion
Number:
5072
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
David Culliford (Southampton, United Kingdom), David Culliford, Matt Johnson, Lynn Josephs. Dealing with missing longitudinal FEV1 observations when used as time-dependent covariate data in survival analysis for COPD patients within a regional UK population-level database. Eur Respir J 2015; 46: Suppl. 59, 5072
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Respiratory parameters predict mortality in COPD patients - data from the Czech multicentre research database of severe COPD.
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014
Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016
Cluster analysis on longitudinal data of patients with adult-onset asthma
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016
COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
The burden of obstructive lung disease (BOLD) methodology overestimates the prevalence of COPD: A 5-year follow-up study
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Detecting specific clusters of asthma and COPD patients using fluctuation based clustering of daily lung function recordings in the BIOAIR study
Source: International Congress 2015 – Any news from the asthma field?
Year: 2015
Heterogeneity in prevalence and underdiagnosis of COPD: Results from BOLD, EPI-SCAN, PLATINO, and PREPOCOL
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data.
Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies
Year: 2021
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up
Source: International Congress 2014 – Markers
Year: 2014
Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
CPOD and lung function parameters as predictors of mortality: Results from the Latin American PLATINO cohort study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Detecting undiagnosed COPD: Using routine primary care data to select and validate candidate variables for COPD risk prediction
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013
Systematic analysis of self-reported comorbidities in the COSYCONET COPD cohort study by stepwise evaluation of medication
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept